XML 53 R31.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Equity [Abstract] |
Schedule of Common Stock Warrants | As of December 31, 2025, the Company had the following common stock warrants outstanding: Schedule of Common Stock Warrants
Issue Date |  | Expiration Date |  | Warrants Outstanding |  |  | Exercise Price |  |  | Offering
1/21/2016 |  | 1/14/2026 |  |  | 28,716 |  |  | $ | 7.56 |  |  | Private placement offering – issued to placement agent
5/2/2016 |  | 5/2/2026 |  |  | 18,175 |  |  |  | 7.56 |  |  | Private placement offering – issued to placement agent
4/28/2017 |  | 4/28/2027 |  |  | 32,458 |  |  |  | 8.42 |  |  | Private placement offering – issued to placement agent
5/17/2017 |  | 5/17/2027 |  |  | 14,969 |  |  |  | 8.42 |  |  | Private placement offering – issued to placement agent
4/8/2021 |  | 4/8/2031 |  |  | 26,042 |  |  |  | 14.40 |  |  | Debt financing – issued to lender
5/30/2024 |  | 5/30/2034 |  |  | 84,227 |  |  |  | 14.84 |  |  | Debt financing – issued to lender
5/30/2024 |  | 5/30/2034 |  |  | 19,649 |  |  |  | 14.84 |  |  | Debt financing – issued to lender
9/9/2025 |  | 9/9/2035 |  |  | 25,269 |  |  |  | 14.84 |  |  | Debt financing – issued to lender
9/9/2025 |  | 9/9/2035 |  |  | 25,268 |  |  |  | 14.84 |  |  | Debt financing – issued to lender
10/18/2023 |  | N/A |  |  | 5,747,787 |  |  |  | 0.001 |  |  | Private placement offering – issued to investors
7/31/2025 |  | N/A |  |  | 400,000 |  |  |  | 0.001 |  |  | Equity offering – issued to underwriters
Total warrants outstanding |  |  | 6,422,560 |  |  |  |  |  |  |
Schedule of Common Stock Warrants Outstanding | The following table summarizes the activity for all common stock warrants outstanding: Schedule of Common Stock Warrants Outstanding
|  | Common stock warrants |  |  | Weighted- average exercise price per share |
Outstanding as of December 31, 2024 |  |  | 11,268,939 |  |  | $ | 4.04 |
Issued |  |  | 450,537 |  |  |  | 1.67 |
Exercised |  |  | (5,282,375 | ) |  |  | 8.07 |
Surrendered upon cashless exercise |  |  | (14,541 | ) |  |  | 10.43 |
Expired |  |  | — |  |  |  | — |
Outstanding as of December 31, 2025 |  |  | 6,422,560 |  |  | $ | 0.53 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration